Researchers in Brazil have found that treating patients who suffer from obstructive sleep apnea (OSA) with continuous positive airway pressure (CPAP) dramatically reduces early indications of atherosclerosis in just months, linking OSA directly to the hardening or narrowing of the arteries.
Studies show that minority patients generally receive a lower quality of health care compared to white patients. How can these disparities be reduced? A supplement to the October 2007 issue of Medical Care Research and Review, published by SAGE, thoroughly explores the effectiveness of health care interventions to answer that question.
Adding ultrasound to mammography finds more cancers than mammography alone, but also substantially increases the number of false positives, according to first-year results from a three-year study of the two tests.
Oncolytics Biotech Inc. (“Oncolytics”) (TSX:ONC, NASDAQ:ONCY) announced that an oral presentation covering interim results from a U.K. Phase Ia/Ib combination REOLYSIN® and radiation clinical trial for patients with advanced or metastatic cancers is scheduled to be presented at the National Cancer Research Institute (NCRI) conference on October 2, 2007 in Birmingham, U.K.
Rice University today unveiled plans for a $100 million initiative to create an institute to develop technologies to combat pressing health problems in the developing world, such as HIV/AIDS and child mortality. The initiative was announced today during the annual meeting of the Clinton Global Initiative in New York.
The Oxford Health Alliance (OxHA), a global coalition with the aim of preventing the epidemic of chronic disease, is launching a groundbreaking public health research programme to enhance scientific knowledge about the effectiveness of community interventions in reducing the prevalence of chronic diseases.
GlaxoSmithKline (NYSE: GSK)announced that it will join with other pharmaceutical companies, academic institutions and the U.S. Food and Drug Administration to research genetic markers that may help predict who is at risk for serious drug-related adverse events.
Following the President’s signature of the Food and Drug Administration (FDA) Amendments Act, HHS Secretary Mike Leavitt praised the bill as an important step forward in ensuring the safety of drugs and medical devices.
To accelerate the advancement of stem cell biology from bench to bedside for treatment of cardiovascular disease, the National Institutes of Health (NIH) will host the scientific symposium Cardiovascular Regenerative Medicine at the NIH Natcher Conference Center in Bethesda, Maryland.
A new study examined the possible associations between occupation and the risk of dying from systemic autoimmune diseases and found that occupational exposures in farming and industry may be linked to higher death rates from these diseases.